Narinex Nasal Drops (Mometasone Furoate)

Adult use

1. Allergic rhinitis Adults (including the elderly) and adolescents aged 12 years and older: Generally, 2 sprays into each nostril once per day (total daily dosage 0.2 mg). When symptoms are alleviated, the maintenance dosage can be reduced to 1 spray into each nostril once per day (total daily dosage 0.1 mg). If symptoms are not alleviated, up to 4 sprays into each nostril can be used once daily (total daily dosage 0.4 mg). 2. Nasal polyps Generally, 2 sprays into each nostril once per day (total daily dosage 0.2 mg). If symptoms do not alleviate after 5 to 6 weeks, the dosage can be increased to 2 sprays into each nostril twice per day (total daily dosage 0.4 mg), and it is recommended to reduce the dosage when symptoms improve. If no symptom reduction is observed after 5 to 6 weeks of twice daily administration, consider other treatment options. There are no studies on the use of this drug for nasal polyp treatment for more than 4 months. 3. Acute sinusitis Generally, 2 sprays into each nostril twice per day (total daily dosage 0.4 mg).

Child use

Children aged 2 to 11 years: Generally, 1 spray into each nostril once per day (total daily dosage 0.1 mg).

This medication should not be administered to certain patients. For instance, patients who have allergies to this medicine or its components or have experienced hypersensitivity reactions should not use it. Furthermore, it should not be used in patients with untreated infections of the nasal mucosa or those who have recently undergone nasal surgery or have wounds or ulcers in the nasal area. In particular, it should not be administered to children under 2 years of age. Patients requiring caution while using this medication include those with active or latent tuberculosis, systemic infections, herpes simplex in the eyes, repeat nosebleeds, those at risk of exposure to chickenpox or measles, patients with severe nasal polyps or nasal obstruction, pregnant women or those who may become pregnant, and breastfeeding women should administer it carefully. While using this medication, various side effects such as headaches, nosebleeds, cough, sore throat, upper respiratory infections may occur. Additionally, rare but serious allergic reactions such as anaphylaxis may arise; if abnormal symptoms appear, use should be stopped immediately and a doctor should be consulted. Long-term high-dose use may lead to systemic side effects and changes or infections in the nasal mucosa, necessitating regular examinations. It is important to check vaccination history due to the risk of chickenpox or measles infection and consult medical personnel immediately if an infection occurs. This medication may affect children's growth; therefore, it should be administered to pediatric patients at the minimal dose cautiously while monitoring growth status regularly. Pregnant women or those breastfeeding should use this medication under medical advice, considering the potential risks and benefits, and should closely monitor the adrenal function of their newborns. This medication can interact with other drugs, especially when used with CYP3A4 inhibitors, increasing the risk of systemic side effects; caution is necessary when co-administered. Before use, adequately shake the container and perform a test spray to ensure a uniform spray; care should be taken not to spray directly into the eyes or septum. Additionally, keep it out of the reach of children, and the effects on driving or machine operation are not known.

Serious side effects

Urticaria, angioedema, difficulty breathing, anaphylaxis, severe allergic reactions, severe edema, nosebleed, septal perforation, liver dysfunction (including jaundice), blurred vision, visual impairment, glaucoma, cataracts, central serous chorioretinopathy, acute bronchospasm, dyspnea, asthma attacks, severe skin adverse reactions, severe rash and blistering with high fever, skin peeling, oral/eye mucosal pain, acute bacterial infection.

Mild side effects

Headaches, viral infections, pharyngitis, nosebleeds, blood-stained mucus, cough, upper respiratory infections, menstrual disorders, musculoskeletal pain, sinusitis, vomiting, joint pain, asthma, bronchitis, chest pain, conjunctivitis, diarrhea, dyspepsia, ear pain, cold symptoms, muscle pain, nausea, rhinitis, nasal inflammation, otitis media, wheezing, skin trauma, throat irritation, nasal symptoms (irritation, itching, dryness, pain, redness, discomfort, etc.), nasal bleeding.

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 2 and 25 degrees Celsius to safely preserve the medication's effectiveness.

Appearance

An opaque suspension that is white or nearly white contained in a bottle that sprays a specific amount each time.

Package unit

For domestic use: 18mL/bottle For export: 18mL/bottle, 12mL/bottle